The Diagnostics Race

Diagnostics companies are seeing competition intensify with several new players & pharma majors entering the space. The result is, disruptive promotional pricing with tests for as low as ₹100. What is the road ahead for incumbent players?

Posted on: 18 May 2022
ViTEEWALK EXECUTIVE TURF
More From ViTEEWALK EXECUTIVE TURF
Future Female Forward
More From Future Female Forward
CNBC-TV18 Digital Exclusives
More From CNBC-TV18 Digital Exclusives